Related Experiment Video
Updated: Feb 10, 2026

Detection of Abnormal Prion Protein by Immunohistochemistry
Published on: May 5, 2023
Interrogating the Dimerization Interface of the Prion Protein Via Site-Specific Mutations to
Sudheer Babu Sangeetham1, Krisztina Huszár2, Petra Bencsura2
1Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.
Abstract:
Transmissible spongiform encephalopathies are centered on the conformational transition of the prion protein from a mainly helical, monomeric structure to a β-sheet rich ordered aggregate. Experiments indicate that the main infectious and toxic species in this process are however shorter oligomers, formation of which from the monomers is yet enigmatic. Here, we created 25 variants of the mouse prion protein site-specifically containing one genetically-incorporated para-benzoyl-phenylalanine (pBpa), a cross-linkable non-natural amino acid, in order to interrogate the interface of a prion protein-dimer, which might lie on the pathway of oligomerization. Our results reveal that the N-terminal part of the prion protein, especially regions around position 127 and 107, is integral part of the dimer interface. These together with additional pBpa-containing variants of mPrP might also facilitate to gain more structural insights into oligomeric and fibrillar prion protein species including the pathological variants.
Insights
Researchers investigated prion protein (PrP) oligomerization, a key process in transmissible spongiform encephalopathies. They identified specific regions of the N-terminal part of the mouse prion protein (mPrP) as crucial for dimer formation during this process.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Transmissible spongiform encephalopathies (TSEs) involve prion protein (PrP) misfolding from helical monomers to beta-sheet-rich aggregates.
- The exact mechanism of infectious and toxic oligomer formation from PrP monomers remains unclear.
Purpose of the Study:
- To investigate the structural basis of prion protein dimer formation, a potential intermediate in oligomerization.
- To identify the specific regions of the prion protein involved in dimer interfaces.
Main Methods:
- Creation of 25 mouse prion protein (mPrP) variants with site-specifically incorporated para-benzoyl-phenylalanine (pBpa), a cross-linkable non-natural amino acid.
- Utilizing pBpa cross-linking to probe the dimer interface of mPrP.
Main Results:
- The N-terminal region of the prion protein, particularly residues near positions 127 and 107, is integral to the dimer interface.
- These findings provide insights into the initial steps of PrP oligomerization.
Conclusions:
- The N-terminal regions of mPrP are critical for forming dimers, a likely step in prion protein aggregation.
- pBpa-containing mPrP variants offer a valuable tool for further structural studies of pathogenic PrP species.
More Related Videos
Related Concept Videos
Protein-protein Interfaces
Protein-Protein Interfaces
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift

